dm+d

46233009

Articles

Search Articles

Refrigerated Storage

Fluenz TetraAstraZeneca

AstraZeneca
Fluenz Tetra
Nasal Spray Suspension

THIS ADVICE APPLIES FOR 2022/2023 INFLUENZA SEASON ONLY
In the event of an inadvertent temperature excursion the following data may be used:
The vaccine may be removed from the refrigerator once for a maximum period of 12 hours at a temperature not above 25°C. Stability data indicates the vaccine components are stable for 12 hours when stored at temperatures from 8°C to 25°C. At the end of this period, Fluenz Tetra should be used immediately or discarded.

Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

UK Health Security Agency has guidance on responding to errors in vaccine storage, handling and administration.

10 August 2022
London MI Service

Influvac sub-unit TetraViatris (Formerly Mylan)

Viatris (Formerly Mylan)
Influvac sub-unit Tetra
Suspension for injection in pre-filled syringe

THIS ADVICE APPLIES FOR 2022/2023 INFLUENZA SEASON ONLY
Contact Viatris in all cases where a deviation from the recommended storage conditions has occurred. Refer to the electronic medicines compendium (eMC) at https://www.medicines.org.uk for company contact details and product literature.

UK Health Security Agency has guidance on responding to errors in vaccine storage, handling and administration.

10 August 2022
London MI Service

Quadrivalent Influenza vaccineSanofi

Sanofi
Quadrivalent Influenza vaccine
Suspension for injection in pre-filled syringe

THIS ADVICE APPLIES FOR 2022/2023 INFLUENZA SEASON ONLY
Contact Sanofi in all cases where a deviation from the recommended storage conditions has occurred. Refer to the electronic medicines compendium (eMC) at https://www.medicines.org.uk for company contact details and product literature.

UK Health Security Agency has guidance on responding to errors in vaccine storage, handling and administration.

10 August 2022
London MI Service

Cell-based quadrivalent influenza vaccineSeqirus

Seqirus
Cell-based quadrivalent influenza vaccine
Suspension for injection in pre-filled syringe

THIS ADVICE APPLIES FOR 2022/2023 INFLUENZA SEASON ONLY
Contact Seqirus in all cases where a deviation from the recommended storage conditions has occurred. Refer to the electronic medicines compendium (eMC) at https://www.medicines.org.uk for company contact details and product literature.

UK Health Security Agency has guidance on responding to errors in vaccine storage, handling and administration.

10 August 2022
London MI Service

SupemtekSanofi

Sanofi
Supemtek
Solution for injection in pre-filled syringe

THIS ADVICE APPLIES FOR 2022/2023 INFLUENZA SEASON ONLY
Contact Sanofi in all cases where a deviation from the recommended storage conditions has occurred. Refer to the electronic medicines compendium (eMC) at https://www.medicines.org.uk for company contact details and product literature.

UK Health Security Agency has guidance on responding to errors in vaccine storage, handling and administration.

10 August 2022
London MI Service

Adjuvant quadrivalent influenza vaccineSeqirus

Seqirus
Adjuvant quadrivalent influenza vaccine
Suspension for injection in pre-filled syringe

THIS ADVICE APPLIES FOR 2022/2023 INFLUENZA SEASON ONLY
Contact Seqirus in all cases where a deviation from the recommended storage conditions has occurred. Refer to the electronic medicines compendium (eMC) at https://www.medicines.org.uk for company contact details and product literature.

UK Health Security Agency has guidance on responding to errors in vaccine storage, handling and administration.

10 August 2022
London MI Service

Lactation Safety Information

Yes
Inactivated (intramuscular or intradermal) or live attenuated (intranasal) vaccines
Live (attenuated) virus in the intranasal vaccine has been adapted to cold in order to replicate in the nasal passage. Survival highly unlikely at breast milk temperatures.
15 October 2018